Fluidigm Q2 Revenues Grow 4 Percent, Miss Wall Street Estimate | GenomeWeb

This story has been updated from a previous version to include comments from Fluidigm's Q2 earnings call.

NEW YORK (GenomeWeb) – Fluidigm said after the close of the market on Thursday that its second quarter revenues grew 4 percent year over year as the company missed analysts' consensus estimate on the top line and significantly reduced its full-year 2015 revenue guidance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.